These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 33493227)

  • 1. Screening, simulation, and optimization design of small molecule inhibitors of the SARS-CoV-2 spike glycoprotein.
    Sun C; Zhang J; Wei J; Zheng X; Zhao X; Fang Z; Xu D; Yuan H; Liu Y
    PLoS One; 2021; 16(1):e0245975. PubMed ID: 33493227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Research Progress on Spike-Dependent SARS-CoV-2 Fusion Inhibitors and Small Molecules Targeting the S2 Subunit of Spike.
    Freidel MR; Armen RS
    Viruses; 2024 Apr; 16(5):. PubMed ID: 38793593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the SARS-CoV-2 spike glycoprotein prefusion conformation: virtual screening and molecular dynamics simulations applied to the identification of potential fusion inhibitors.
    Romeo A; Iacovelli F; Falconi M
    Virus Res; 2020 Sep; 286():198068. PubMed ID: 32565126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular screening of glycyrrhizin-based inhibitors against ACE2 host receptor of SARS-CoV-2.
    Ahmad S; Waheed Y; Abro A; Abbasi SW; Ismail S
    J Mol Model; 2021 Jun; 27(7):206. PubMed ID: 34169390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Updated Review on Betacoronavirus Viral Entry Inhibitors: Learning from Past Discoveries to Advance COVID-19 Drug Discovery.
    Sabbah DA; Hajjo R; Bardaweel SK; Zhong HA
    Curr Top Med Chem; 2021; 21(7):571-596. PubMed ID: 33463470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of SARS-CoV-2 Receptor Binding Inhibitors by In Vitro Screening of Drug Libraries.
    David AB; Diamant E; Dor E; Barnea A; Natan N; Levin L; Chapman S; Mimran LC; Epstein E; Zichel R; Torgeman A
    Molecules; 2021 May; 26(11):. PubMed ID: 34072087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Insights into Small-Molecule Drug Discovery for SARS-CoV-2.
    Su H; Zhou F; Huang Z; Ma X; Natarajan K; Zhang M; Huang Y; Su H
    Angew Chem Int Ed Engl; 2021 Apr; 60(18):9789-9802. PubMed ID: 32729180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Withanone from
    Balkrishna A; Pokhrel S; Singh H; Joshi M; Mulay VP; Haldar S; Varshney A
    Drug Des Devel Ther; 2021; 15():1111-1133. PubMed ID: 33737804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why All the Fury over Furin?
    Osman EEA; Rehemtulla A; Neamati N
    J Med Chem; 2022 Feb; 65(4):2747-2784. PubMed ID: 34340303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of Novel Spike Inhibitors against SARS-CoV-2 Infection.
    Tai LT; Yeh CY; Chang YJ; Liu JF; Hsu KC; Cheng JC; Lu CH
    Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of ACE2-Spike Interaction by an ACE2 Binder Suppresses SARS-CoV-2 Entry.
    Shin YH; Jeong K; Lee J; Lee HJ; Yim J; Kim J; Kim S; Park SB
    Angew Chem Int Ed Engl; 2022 Mar; 61(11):e202115695. PubMed ID: 35043545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecules targeting a novel homotrimer cavity of Spike protein attenuate replication of SARS-CoV-2.
    Daniels A; Padariya M; Fletcher S; Ball K; Singh A; Carragher N; Hupp T; Tait-Burkard C; Kalathiya U
    Antiviral Res; 2024 Aug; 228():105949. PubMed ID: 38942150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of Highly Potent Fusion Inhibitors with Potential Pan-Coronavirus Activity That Effectively Inhibit Major COVID-19 Variants of Concern (VOCs) in Pseudovirus-Based Assays.
    Curreli F; Ahmed S; Victor SMB; Drelich A; Panda SS; Altieri A; Kurkin AV; Tseng CK; Hillyer CD; Debnath AK
    Viruses; 2021 Dec; 14(1):. PubMed ID: 35062273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of S-protein RBD and hACE2 Interaction for Control of SARSCoV- 2 Infection (COVID-19).
    Nayak SK
    Mini Rev Med Chem; 2021; 21(6):689-703. PubMed ID: 33208074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tinocordiside from
    Balkrishna A; Pokhrel S; Varshney A
    Comb Chem High Throughput Screen; 2021; 24(10):1795-1802. PubMed ID: 33172372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simulation of Molecular Dynamics of SARS-CoV-2 S-Protein in the Presence of Multiple Arbidol Molecules: Interactions and Binding Mode Insights.
    Borisevich SS; Khamitov EM; Gureev MA; Yarovaya OI; Rudometova NB; Zybkina AV; Mordvinova ED; Shcherbakov DN; Maksyutov RA; Salakhutdinov NF
    Viruses; 2022 Jan; 14(1):. PubMed ID: 35062323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Dual-Targeted Fusion Inhibitor Clofazimine Binds to the S2 Segment of the SARS-CoV-2 Spike Protein.
    Freidel MR; Vakhariya PA; Sardarni SK; Armen RS
    Viruses; 2024 Apr; 16(4):. PubMed ID: 38675980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the efficacy of naturally occurring biflavone based antioxidants towards the inhibition of the SARS-CoV-2 spike glycoprotein mediated membrane fusion.
    Mondal S; Karmakar A; Mallick T; Begum NA
    Virology; 2021 Apr; 556():133-139. PubMed ID: 33571798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The binding of heparin to spike glycoprotein inhibits SARS-CoV-2 infection by three mechanisms.
    Paiardi G; Richter S; Oreste P; Urbinati C; Rusnati M; Wade RC
    J Biol Chem; 2022 Feb; 298(2):101507. PubMed ID: 34929169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting SARS-CoV-2 Spike Protein/ACE2 Protein-Protein Interactions: a Computational Study.
    Pirolli D; Righino B; De Rosa MC
    Mol Inform; 2021 Jun; 40(6):e2060080. PubMed ID: 33904240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.